T1	Pharmacological_substance 25 36	doxorubicin
N1000 	Reference T1 MeSH:D004317	doxorubicin
T2	Disorder 40 47	myeloma
N1 	Reference T2 UMLS:C0026764	myeloma
T3	Pharmacological_substance 67 78	thalidomide
N1001 	Reference T3 MeSH:D013792	thalidomide
T4	Disorder 137 144	myeloma
N2 	Reference T4 UMLS:C0026764	myeloma
T5	Disorder 200 222	deep venous thrombosis
N3 	Reference T5 UMLS:C0149871	deep venous thrombosis
T6	Pharmacological_substance 230 241	Thalidomide
N1002 	Reference T6 MeSH:D013792	Thalidomide
T7	Disorder 276 292	multiple myeloma
N4 	Reference T7 UMLS:C0026764	multiple myeloma
T8	Pharmacological_substance 325 336	thalidomide
N1003 	Reference T8 MeSH:D013792	thalidomide
T9	Pharmacological_substance 576 587	thalidomide
N1004 	Reference T9 MeSH:D013792	thalidomide
T10	Pharmacological_substance 642 653	doxorubicin
N1005 	Reference T10 MeSH:D004317	doxorubicin
T11	Pharmacological_substance 671 684	dexamethasone
N1006 	Reference T11 MeSH:D003907	dexamethasone
T12	Pharmacological_substance 685 696	thalidomide
N1007 	Reference T12 MeSH:D013792	thalidomide
T13	Pharmacological_substance 697 706	cisplatin
N1008 	Reference T13 MeSH:D002945	cisplatin
T14	Pharmacological_substance 707 718	doxorubicin
N1009 	Reference T14 MeSH:D004317	doxorubicin
T15	Pharmacological_substance 719 735	cyclophosphamide
N1010 	Reference T15 MeSH:D003520	cyclophosphamide
T16	Pharmacological_substance 736 745	etoposide
N1011 	Reference T16 MeSH:D005047	etoposide
T17	Pharmacological_substance 857 870	dexamethasone
N1012 	Reference T17 MeSH:D003907	dexamethasone
T18	Pharmacological_substance 871 887	cyclophosphamide
N1013 	Reference T18 MeSH:D003520	cyclophosphamide
T19	Pharmacological_substance 888 897	etoposide
N1014 	Reference T19 MeSH:D005047	etoposide
T20	Pharmacological_substance 898 907	cisplatin
N1015 	Reference T20 MeSH:D002945	cisplatin
T21	Pharmacological_substance 908 919	thalidomide
N1016 	Reference T21 MeSH:D013792	thalidomide
T22	Pharmacological_substance 1318 1329	doxorubicin
N1017 	Reference T22 MeSH:D004317	doxorubicin
T24	Pharmacological_substance 1435 1446	thalidomide
N1018 	Reference T24 MeSH:D013792	thalidomide
T25	Pharmacological_substance 1451 1462	doxorubicin
N1019 	Reference T25 MeSH:D004317	doxorubicin
T26	Disorder 1494 1497	DVT
N5 	Reference T26 UMLS:C0149871	DVT
N6 	Reference T26 UMLS:C0151950	DVT
N7 	Reference T26 UMLS:C0149871	DVT
T31	Disorder 224 227	DVT
N8 	Reference T31 UMLS:C0149871	DVT
N9 	Reference T31 UMLS:C0151950	DVT
N10 	Reference T31 UMLS:C0149871	DVT
T32	Disorder 294 297	MM)
N11 	Reference T32 UMLS:C0026764	MM)
T33	Disorder 506 509	DVT
N12 	Reference T33 UMLS:C0149871	DVT
N13 	Reference T33 UMLS:C0151950	DVT
N14 	Reference T33 UMLS:C0149871	DVT
T34	Disorder 517 519	MM
N15 	Reference T34 UMLS:C0026764	MM
T23	Disorder 472 475	DVT
N16 	Reference T23 UMLS:C0149871	DVT
N17 	Reference T23 UMLS:C0151950	DVT
N18 	Reference T23 UMLS:C0149871	DVT
T35	Disorder 1019 1022	DVT
N19 	Reference T35 UMLS:C0149871	DVT
N20 	Reference T35 UMLS:C0151950	DVT
N21 	Reference T35 UMLS:C0149871	DVT
T36	Disorder 1219 1222	DVT
N22 	Reference T36 UMLS:C0149871	DVT
N23 	Reference T36 UMLS:C0151950	DVT
N24 	Reference T36 UMLS:C0149871	DVT
T37	Disorder 1275 1278	DVT
N25 	Reference T37 UMLS:C0149871	DVT
N26 	Reference T37 UMLS:C0151950	DVT
N27 	Reference T37 UMLS:C0149871	DVT
T27	Subject 48 56	patients
T38	Pharmacological_substance 179 191	chemotherapy
N1020 	Reference T38 MeSH:C403362	chemotherapy
N1021 	Reference T38 MeSH:D004113	chemotherapy
N1022 	Reference T38 MeSH:C057647	chemotherapy
T41	Combination 379 390	combination
T42	Pharmacological_substance 406 418	chemotherapy
N1023 	Reference T42 MeSH:C403362	chemotherapy
N1024 	Reference T42 MeSH:D004113	chemotherapy
N1025 	Reference T42 MeSH:C057647	chemotherapy
T44	Speculation_cue 464 468	risk
T48	Subject 513 516;520 528	232 patients
T49	Combination 544 555	combination
T50	Pharmacological_substance 559 571	chemotherapy
N1026 	Reference T50 MeSH:C403362	chemotherapy
N1027 	Reference T50 MeSH:D004113	chemotherapy
N1028 	Reference T50 MeSH:C057647	chemotherapy
T53	Speculation_cue 480 488	analyzed
T59	Pharmacological_substance 1295 1307	chemotherapy
N1029 	Reference T59 MeSH:C403362	chemotherapy
N1030 	Reference T59 MeSH:D004113	chemotherapy
N1031 	Reference T59 MeSH:C057647	chemotherapy
T61	Speculation_cue 1475 1479	risk
T62	Combination 1447 1450	and
T63	Disorder 1410 1412	MM
N28 	Reference T63 UMLS:C0026764	MM
T64	Subject 1413 1421	patients
T57	Pharmacological_substance 662 669	DT-PACE
T58	Pharmacological_substance 849 855	DCEP-T
T67	Pharmacological_substance 1158 1165	DT-PACE
T68	Negation_cue 1170 1173	not
T69	Pharmacological_substance 1174 1180	DCEP-T
